Literature DB >> 30770586

Improvements cardiometabolic risk factors in Latin American Amerindians (the Mapuche) with concurrent training.

Cristian Álvarez1, Robinson Ramírez-Vélez2, Rodrigo Ramírez-Campillo1, Alejandro Lucia3, Alicia M Alonso-Martinez2, Harry Faúndez4, Eduardo L Cadore5, Mikel Izquierdo2.   

Abstract

Our aim was to investigate the effects of 12 weeks of CT (ie, high-intensity interval and resistance training) in Mapuche adults from Chile and in their peers of European descent. In total, 96 hyperglycemic adult women (mean age 46 years [95% confidence interval; 38, 53]) were divided in four groups: Mapuche CT (Map-CT, n = 14) or control group (Map-CG, n = 44), and European CT (Eur-CT, n = 14) or control group (Eur-CG, n = 23). The following endpoints were analyzed at baseline and after 12 weeks: anthropometric (body mass, body mass index, waist circumference), body composition (fat mass, muscle mass, lean mass), cardiovascular (systolic [SBP]/diastolic [DBP] blood pressure), metabolic (blood fasting glucose and total cholesterol), and muscle strength (handgrip of dominant/non-dominant arm). There were significant positive changes in body mass, body fat, and muscle mass (P < 0.0001) in both Map-CT and Eur-CT groups, whereas waist circumference was decreased significantly only in the Eur-CT group (P < 0.0001). Both Map-CT and Eur-CT groups showed decreased levels of fasting glucose (P < 0.05) and total cholesterol after the intervention (P < 0.0001). Also, both Map-CT (P < 0.05) and Eur-CT (P = 0.01) groups showed a lowered SBP. Finally, significant increases were observed after training in handgrip strength (dominant arm) in Map-CT and Eur-CT groups (both P < 0.0001). CT led to similar improvements in cardiometabolic risk factors for metabolic syndrome development in Mapuche and European participants, with additional improvements in other anthropometric, body composition, cardiovascular, metabolic, and muscle strength parameters related to the prevention of metabolic syndrome. These results suggest future more complex studies.
© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  European; Mapuche Amerindians; concurrent training; ethnicity; risk factors

Mesh:

Substances:

Year:  2019        PMID: 30770586     DOI: 10.1111/sms.13409

Source DB:  PubMed          Journal:  Scand J Med Sci Sports        ISSN: 0905-7188            Impact factor:   4.221


  5 in total

1.  High-intensity interval training improves metabolic syndrome and body composition in outpatient cardiac rehabilitation patients with myocardial infarction.

Authors:  Yaoshan Dun; Randal J Thomas; Joshua R Smith; Jose R Medina-Inojosa; Ray W Squires; Amanda R Bonikowske; Hsuhang Huang; Suixin Liu; Thomas P Olson
Journal:  Cardiovasc Diabetol       Date:  2019-08-14       Impact factor: 9.951

2.  Exercise Training as a Treatment for Cardiometabolic Risk in Sedentary Adults: Are Physical Activity Guidelines the Best Way to Improve Cardiometabolic Health? The FIT-AGEING Randomized Controlled Trial.

Authors:  Francisco J Amaro-Gahete; Alejandro De-la-O; Lucas Jurado-Fasoli; Borja Martinez-Tellez; Jonatan R Ruiz; Manuel J Castillo
Journal:  J Clin Med       Date:  2019-12-01       Impact factor: 4.241

3.  Effect of a 12-Week Concurrent Training Intervention on Cardiometabolic Health in Obese Men: A Pilot Study.

Authors:  Francisco J Amaro-Gahete; Jesús G Ponce-González; Juan Corral-Pérez; Daniel Velázquez-Díaz; Carl J Lavie; David Jiménez-Pavón
Journal:  Front Physiol       Date:  2021-02-11       Impact factor: 4.566

4.  Changes in VO2max and cardiac output in response to short-term high-intensity interval training in Caucasian and Hispanic young women: A pilot study.

Authors:  Jamie L De Revere; Rasmus D Clausen; Todd A Astorino
Journal:  PLoS One       Date:  2021-01-22       Impact factor: 3.240

5.  Similar Adaptations to 10 Weeks Concurrent Training on Metabolic Markers and Physical Performance in Young, Adult, and Older Adult Women.

Authors:  David C Andrade; Marcelo Flores-Opazo; Luis Peñailillo; Pedro Delgado-Floody; Johnattan Cano-Montoya; Jaime A Vásquez-Gómez; Cristian Alvarez
Journal:  J Clin Med       Date:  2021-11-27       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.